For example, a triple agonist, retatrutide, targets GIP, GLP-1 and glucagon
Even with dual-agonist appetite suppression, hyperpalatable foods can undermine weight loss
It can also be used to lower the risk of heart attack, stroke, and cardiovascular death in adults with both Type 2 diabetes and heart disease
GLP-1 medications are prescription treatments that require evaluation by a licensed clinician
GLP-1 agonists are actually being studied for treating liver conditions like metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) because they reduce fat in the liver, improve enzymes, and may slow disease progression
Studies on Chemotherapy-Induced Neuropathy CIN is a common side effect of cancer treatment